AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease, including in older adults, in final-stage U.S. testing, the company announced Monday.

Bangladesh does not plan to suspend its rollout of the AstraZeneca vaccine, despite a cascading number of countries doing so over reports of some recipients developing dangerous blood clots.

With coronavirus cases rising in many places, governments faced the grimmest of dilemmas Tuesday: push on with a vaccine that is known to save lives or suspend use of AstraZeneca over reports of dangerous blood clots in a few recipients, even as the European regulator said there was "no indication" the shot was responsible.

A cascading number of European countries — including Germany, France, Italy and Spain — suspended use of AstraZeneca’s COVID-19 vaccine Monday over reports of dangerous blood clots in some recipients, though the company and international regulators say there is no evidence the shot is to blame.